Publisher: Cambridge Scholars Publishing in association with GSE Research
ISSN: 1540-1405
Source: Journal of the National Comprehensive Cancer Network (JNCCN), Vol.3, Iss.1, 2005-01, pp. : 105-113
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sunitinib surpasses standard therapy for metastatic renal cancer
Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. :
CCI 779 active in refractory metastatic renal cancer
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :
Adjuvant nephrectomy beneficial in metastatic renal cancer
Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. :
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. :